NutriBand Inc.
NTRBNasdaqHealthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|---|
| Revenue | $2.0M | $2.1M | $2.1M | $2.1M | $1.2M | $737,519 |
| Operating income | −$8.3M | −$10.3M | −$4.9M | −$4.5M | −$6.1M | −$2.6M |
| Net income | −$8.2M | −$10.5M | −$5.5M | −$4.5M | −$6.2M | −$2.9M |
| Total assets | $7.5M | $7.5M | $7.5M | $9.5M | $12.7M | $9.9M |
| Total liabilities | $868,447 | $1.0M | $1.1M | $883,387 | $880,375 | $2.8M |
| Equity | $6.7M | $6.4M | $6.4M | $8.6M | $11.9M | $7.1M |
| EPS (diluted) | $-2.58 | $-0.99 | $-0.69 | $-0.53 | $-0.80 | $-0.51 |
| Shares out. | 12.2M | 11.2M | 11.0M | 7.8M | 7.8M | 6.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- −408.4%
- Net margin
- −404.1%
- Return on equity
- −123.2%
- Return on assets
- −109.0%
- Return on capital (ROCE)
- −123.0%
- Liabilities / assets
- 11.5%
- Debt / equity
- 0.13×
- Book value / share
- $0.55
- Revenue growth (YoY)
- −4.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- -15.84distress
- Accruals / assets
- −41.0%clean
- Beneish M-Score
- -3.73normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗May 1, 2024
- NT 10-Qmissed a reporting deadline ↗Sep 17, 2018
- NT 10-Qmissed a reporting deadline ↗Jun 14, 2018
- NT 10-Qmissed a reporting deadline ↗Sep 14, 2017
- NT 10-Qmissed a reporting deadline ↗Jun 14, 2017
- NT 10-Kmissed a reporting deadline ↗May 4, 2017
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Melnik SergueiActivist (13D)Mar 13, 2025
- Sheridan GarethActivist (13D)Mar 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Melnik SergueiOfficer — Chairman and President | Mar 6, 2023 | Gift | 5,000 | $0.00 |
| Sheridan GarethOfficer — CEO | May 10, 2022 | Grant | 10,000 | $3.80 |
| Melnik SergueiOfficer — Chairman and President | Feb 24, 2022 | Buy | 5,000 | $4.03 |
| Melnik SergueiOfficer — Chairman and President | Feb 6, 2022 | Gift | 10,000 | $0.00 |
| Melnik SergueiOfficer — CFO | May 30, 2019 | Gift | 20,000 | $0.00 |
| Davidov MichaelDirector | Jul 31, 2018 | Grant | 5,000 | $0.00 |
| Melnik SergueiOfficer — CFO | Aug 19, 2017 | Gift | 450,000 | $0.00 |
| Sheridan GarethOfficer — CEO | Aug 17, 2017 | Gift | 1.0M | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 185,933 | 17.4 | -9.1% |
| Apr 30, 2026 | 204,443 | 27.3 | -3.5% |
| Apr 15, 2026 | 211,943 | 32.4 | -2.6% |
| Mar 31, 2026 | 217,557 | 15.3 | +9.2% |
| Mar 13, 2026 | 199,152 | 13.4 | -2.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureApr 7, 2026
- Regulation FD disclosureFeb 13, 2026
- Shareholder voteFeb 3, 2026
- Regulation FD disclosureDec 30, 2025
- Regulation FD disclosureOct 28, 2025
- Regulation FD disclosureSep 3, 2025
- Unregistered equity sale · Amended charter or bylawsAug 7, 2025
- Amended charter or bylawsJul 16, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-K/AAMENDMENT NO. 1 TO FORM 10-KMay 18, 2026
- 10-KANNUAL REPORTApr 29, 2026
- 8-KCURRENT REPORTApr 7, 2026
- 8-KCURRENT REPORTFeb 13, 2026
- 424B3PROSPECTUS SUPPLEMENTFeb 13, 2026
- 8-KCURRENT REPORTFeb 3, 2026
- 8-KCURRENT REPORTDec 30, 2025
- DEF 14APROXY STATEMENTDec 19, 2025
- 10-QQUARTERLY REPORTDec 11, 2025
- 5Nov 25, 2025
- 8-KCURRENT REPORTOct 28, 2025
- 5Oct 21, 2025
- 424B3PROSPECTUS SUPPLEMENTOct 20, 2025
- 10-QQUARTERLY REPORTSep 9, 2025
- 8-KCURRENT REPORTSep 3, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.